Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Superior hypogastric plexus injection with botulinum toxin type A for chronic pelvic pain in endometriosis
TCTR20250321001Phase 2Unknown
- Sponsor
- Ratchadaphiseksomphot Endowment Fund
- Start
- Oct 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of botulinum toxin type A in endometriosis, chronic prostatitis (CP), sponsored by Ratchadaphiseksomphot Endowment Fund. Status: unknown.
02
Drugs
botulinum toxin type A
03
Conditions
endometriosischronic prostatitis (CP)
Beyond the preview
Go deeper on TCTR20250321001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250321001.